The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Machine Learning (ML) in The Pharmaceutical Industry Market From 2026 To 2030?
The market size for machine learning (ml) in the pharmaceutical industry has seen significant growth in recent years. It is anticipated to increase from $4.08 billion in 2025 to $5.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 35.4%. This historical growth can be linked to several factors, including heightened R&D investment in the pharmaceutical sector, the integration of AI and ML into drug discovery, an increasing incidence of chronic diseases, advancements in computational biology, and collaborations between pharmaceutical and technology companies.
The machine learning (ml) in the pharmaceutical industry market is poised for significant growth in the coming years, with its size expected to reach $18.71 billion by 2030, growing at a compound annual growth rate (CAGR) of 35.7%. This projected expansion is largely due to the increasing incorporation of AI in clinical trials, the broader application of precision medicine, a rise in the use of real-world data analytics, progress in cloud-based pharmaceutical platforms, and the creation of personalized therapeutics. Throughout the forecast period, key trends will include predictive drug discovery models, optimized clinical trials, the utilization of real-world evidence data, the implementation of personalized medicine, and automated regulatory compliance.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13872&type=smp
What Major Drivers Are Influencing Demand In The Machine Learning (ML) in The Pharmaceutical Industry Market?
The expanding adoption of artificial intelligence (AI) is propelling machine learning (ML) within the pharmaceutical industry. AI functions as computer software that replicates human cognitive abilities for intricate tasks such as analysis, reasoning, and learning, while ML is a subset of AI that utilizes algorithms trained on data to generate models capable of performing complex operations. Both AI and ML have been deployed in pharmaceutical technology and drug delivery design, providing accelerated answers to challenging issues. These capabilities have the potential to revolutionize the drug delivery process, enhance tools for decision-making, and manage vast amounts of data for more effective conclusions. For example, in June 2023, Forbes, a US-based business magazine, indicated that approximately 432,000 UK organizations, or one in six, had embraced at least one AI technology. Additionally, at least one AI technology had been adopted by 68% of large businesses, 33% of medium-sized businesses, and 15% of small businesses. Thus, the growing implementation of artificial intelligence (AI) will be a driving force for machine learning (ML) in the pharmaceutical industry.
Which Segments Are Included In The Analysis Of The Machine Learning (ML) in The Pharmaceutical Industry Market?
The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –
1) By Component: Solution, Services
2) By Deployment: Cloud, On-premise
3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises
Subsegments:
1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications
2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services
Which Trends Are Impacting The Growth Of The Machine Learning (ML) in The Pharmaceutical Industry Market?
Major companies in the pharmaceutical industry that utilize machine learning (ML) are concentrating on developing user-friendly software platforms, such as drug discovery software, to bolster their drug discovery capabilities. Drug discovery software is a comprehensive term covering various specialized tools and platforms used throughout the process of identifying and developing new pharmaceutical drugs. For example, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, launched the AIDDISON drug discovery software. This represents the first software-as-a-service platform to integrate drug discovery and synthesis by employing generative AI, machine learning, and computer-aided drug design. The platform allows laboratories to identify fitting drug candidates within an extensive chemical space, virtually screen compounds from a vast universe of over 60 billion chemical targets, and evaluate synthesis routes for manufacturing drugs that are safer, more cost-effective, and yield higher quantities.
Which Key Industry Participants Are Active In The Machine Learning (ML) in The Pharmaceutical Industry Market?
Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs
Read the full machine learning (ml) in the pharmaceutical industry market report here:
Which Region Shows The Strongest Potential For Future Growth In The Machine Learning (ML) in The Pharmaceutical Industry Market?
North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Machine Learning (ML) in The Pharmaceutical Industry Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13872&type=smp
Browse Through More Reports Similar to the Global Machine Learning (ML) in The Pharmaceutical Industry Market 2026, By The Business Research Company
Machine Learning Ml In The Pharmaceutical Industry Market Report 2026
Artificial Intelligence In Drug Discovery Market Report 2026
Artificial Intelligence Ai In Biopharmaceuticals Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model